Electrochemical oxidation of ferrocene: a strong dependence on the concentration of the supporting electrolyte for nonpolar solvents D Bao, B Millare, W Xia, BG Steyer, AA Gerasimenko, A Ferreira, ... The Journal of Physical Chemistry A 113 (7), 1259-1267, 2009 | 181 | 2009 |
Scarless genome editing of human pluripotent stem cells via transient puromycin selection B Steyer, Q Bu, E Cory, K Jiang, S Duong, D Sinha, S Steltzer, D Gamm, ... Stem cell reports 10 (2), 642-654, 2018 | 79 | 2018 |
Human iPSC modeling reveals mutation-specific responses to gene therapy in a genotypically diverse dominant maculopathy D Sinha, B Steyer, PK Shahi, KP Mueller, R Valiauga, KL Edwards, ... The American Journal of Human Genetics 107 (2), 278-292, 2020 | 49 | 2020 |
Drug-loaded nanoparticles induce gene expression in human pluripotent stem cell derivatives V Gajbhiye, L Escalante, G Chen, A Laperle, Q Zheng, B Steyer, S Gong, ... Nanoscale 6 (1), 521-531, 2014 | 35 | 2014 |
High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells B Steyer, J Carlson-Stevermer, N Angenent-Mari, A Khalil, T Harkness, ... Acta biomaterialia 34, 143-158, 2016 | 33 | 2016 |
High-content analysis of CRISPR-Cas9 gene-edited human embryonic stem cells J Carlson-Stevermer, M Goedland, B Steyer, A Movaghar, M Lou, ... Stem cell reports 6 (1), 109-120, 2016 | 32 | 2016 |
Developing precision medicine using scarless genome editing of human pluripotent stem cells B Steyer, E Cory, K Saha Drug Discovery Today: Technologies 28, 3-12, 2018 | 12 | 2018 |
Inorganic coatings for the enhancement of chemical transfection WL Murphy, AS Khalil, X Yu, K Saha, JM Carlson-Stevermeyer, BG Steyer US Patent App. 14/871,327, 2016 | 5 | 2016 |
Gene therapies differentially rescue disease phenotype in patient-specific hiPSC-RPE models of Best disease D Sinha, B Steyer, PK Shahi, R Valiauga, KL Edwards, C Bacig, ... Investigative Ophthalmology & Visual Science 60 (9), 3390-3390, 2019 | 1 | 2019 |
Developing Gene Therapies for Inherited Retinal Dystrophies Using CRISPR/Cas9 Genomic Editing and Human Pluripotent Stem Cells A Abdeen, B Steyer, J Carlson-Stevermer, G Chen, Y Wang, R Xie, ... MOLECULAR THERAPY 27 (4), 255-255, 2019 | | 2019 |
335. High Content Analysis Platform for Optimization of Lipid Mediated CRISPR-Cas9 Delivery Strategies in Human Cells B Steyer, J Carlson-Stevermer, N Angenent-Mari, A Khalil, T Harkness, ... Molecular Therapy 24, S133, 2016 | | 2016 |
575. High Content Analysis of CRISPR-Cas9 Gene-Edited Human Embryonic Stem Cells J Carlson-Stevermer, M Goedland, B Steyer, A Movaghar, M Lou, ... Molecular Therapy 24, S229-S230, 2016 | | 2016 |
Toward" Rainbow Retinas" that Dynamically Report on Retinal Cell Differentiation in Patient-Specific Stem Cells B Steyer, E Capowski, D Gamm, K Saha TISSUE ENGINEERING PART A 21, S195-S195, 2015 | | 2015 |
The Role of Syndecan‐1 in Arterial Mechanotransduction AB Baker, V Chitalia, BG Steyer, S Hirji, ER Edelman The FASEB Journal 24, 480.1-480.1, 2010 | | 2010 |
STATEMENT OF SIGNIFICANCE B Steyer, J Carlson-Stevermer, N Angenent-Mari, A Khalil, T Harkness, ... | | |